Formulation Composition
Active Ingredients & Strength
Hydroxyzine Hydrochloride IP10 mg
ExcipientsQ.S.
IP β Indian Pharmacopoeia | USP β United States Pharmacopeia | BP β British Pharmacopoeia | Q.S. β Quantum Sufficit (sufficient quantity). All ingredients meet pharmaceutical-grade purity standards.
Therapeutic Indications
- Pruritus associated with allergic disorders: Provides rapid relief from severe itching, hives, and skin redness caused by various allergic dermatoses.
- Pruritus associated with emotional disorders: Effectively alleviates and manages chronic itching triggered or exacerbated by anxiety, stress, or emotional tension.
Indications listed are general to the category. Specific use should be as per physician's clinical assessment.
Key Clinical Benefits
Allergy Symptom Relief: Helps reduce itching, skin irritation, and allergic discomfort.
Fights the Unknown: Your aid from allergies caused by unknown reasons.
Calming Effect: Supports relaxation and comfort in patients experiencing anxiety or restlessness when prescribed.
Improved Patient Comfort: Provides relief from allergy-related symptoms affecting quality of life.
Packaging Configuration
Pack Type
Aluminium-Aluminium Blister
All packaging conforms to Schedule M GMP standards of the Drugs & Cosmetics Act, 1940.
Safety & Precautions
- Hydroxyzine: May cause sedation; avoid driving or alcohol use concurrently.
- Fluconazole: Contraindicated in patients taking certain medications (e.g., Terfenadine, Cisapride) β check interactions.
- Report any signs of liver dysfunction (jaundice, dark urine) immediately.
- Topical and systemic antifungals have different applications β do not interchange without medical advice.
- Complete the full prescribed course to prevent fungal resistance.
Schedule H Prescription Drug β Rx Only
This medicine is sold by retail on the prescription of a Registered Medical Practitioner only. It is not to be recommended or used without a doctor's prescription. Not for Over-The-Counter (OTC) sale. As per the Drugs & Cosmetics Act, 1940, and Rules 1945.
This information is intended for qualified healthcare professionals and pharma trade partners. It is not a substitute for professional medical advice, diagnosis or treatment.